cigna glp 1 2025 requirements is ending employee coverage for GLP-1 weight-loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Cigna drops coverage of GLP-1
Description
S5A and F), indicators of fibrosis

PMCID: PMC5764193

Lawsuits primarily allege gastroparesis and ileus (intestinal blockage)

L.BanerjiM

Patients without gastrointestinal symptoms may not receive a diagnosis until cough prompts an evaluation
